Plant disease control composition and its use

ABSTRACT

A plant disease control composition comprising a carboxamide compound represented by following formula (I), wherein R 1  represents a hydrogen atom or a methyl group, and R 2  represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more QoI compounds selected from group (A) consisting of dimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin, kresoxim-methyl, picoxystrobin, trifloxystrobin and N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide is provided by the present invention, and this composition has excellent effect for controlling a plant disease.

TECHNICAL FIELD

The present invention relates to a plant disease control composition andits use.

BACKGROUND ART

Many compounds have been developed for controlling plant diseases andactually used (see, for example, PTL 1 and 2).

CITATION LIST Patent Literature

[PTL 1]: WO86/02641

[PTL 2]: WO92/12970

SUMMARY OF INVENTION Technical Problem

An object of the present invention is to provide a composition having anexcellent effect for controlling plant disease.

Solution to Problem

The inventor of the present invention studied for seeking a compositionhaving an excellent effect for controlling plant disease and found thata composition comprising a carboxamide compound represented by thefollowing formula (I) and one or more QoI compounds selected fromfollowing group (A) has an excellent effect for plant diseases and thencompleted the present invention.

The present invention provides the following [1] to [5].

[1] A plant disease control composition comprising a carboxamidecompound represented by formula (I):

wherein

R¹ represents a hydrogen atom or a methyl group, and

R²represents a methyl group, a difluoromethyl group or a trifluoromethylgroup,

and one or more QoI compounds selected from group (A) consisting ofdimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin,kresoxim-methyl, picoxystrobin, trifloxystrobin andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide.

[2] The plant disease control composition according to above [I],wherein the weight ratio of the carboxamide compound to the QoIcompound(s) is from 0.1/1 to 10/1 of the carboxamide compound/the QoIcompound(s).

[3] A method of controlling plant disease which comprises a step oftreating a plant or the soil where a plant grows with an effectiveamount of a carboxamide compound represented by formula (I):

wherein

R¹ represents a hydrogen atom or a methyl group, and

R² represents a methyl group, a difluoromethyl group or atrifluoromethyl group,

and one or more QoI compounds selected from group (A) consisting ofdimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin,kresoxim-methyl, picoxystrobin, tri-floxystrobin andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide.

[4] The method of controlling plant disease according to above [3],wherein the weight ratio of the carboxamide compound to the QoIcompound(s) is from 0.1/1 to 10/1 of the carboxamide compound/the QoIcompound(s).

[5] The method of controlling plant disease according to above [3] or[4], wherein the plant or the soil where a plant grows is soybean or thesoil where soybean grows, respectively.

Advantageous Effect of Invention

According to the present invention, various plant diseases can becontrolled.

DESCRIPTION OF EMBODIMENTS

The plant disease control composition of the present invention(hereinafter referred to as “composition”) comprises a carboxamidecompound represented by formula (I):

wherein

R¹ and R² represent the same meanings as defined in the above(hereinafter “carboxamide compound”)

and one or more QoI compounds selected from group (A) consisting ofdimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin,kresoxim-methyl, picoxystrobin, trifloxystrobin andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(hereinafter referred to as “QoI compound”).

The “carboxamide compound” are those as described in, for example,WO86/02641 or WO92/12970, and can be prepared by the method describedtherein.

Particular examples of the “carboxamide compounds” are as follows:

carboxamide compound represented by formula (1):

(hereinafter referred to as “carboxamide compound (1)”);

carboxamide compound represented by formula (2):

(hereinafter referred to as “carboxamide compound (2)”);

carboxamide compound represented by formula (3):

(hereinafter referred to as “carboxamide compound (3)”):

carboxamide compound represented by formula (4):

(hereinafter referred to as “carboxamide compound (4)”);

carboxamide compound represented by formula (5):

(hereinafter referred to as “carboxamide compound (5)”).

The “QoI compounds” are known compounds and described in, for example,“THE PESTICIDE MANUAL—14^(th) EDITION (published by BCPC) ISBN1901396142 and WO 95/27693. These compounds can be obtained from theproducts containing said compound in the market or can be synthesized bypublicly known methods.

The weight ratio of the “carboxamide compound” to the “QoI compound(s)”in the “composition” is usually from 0.01/1 to 500/1, and preferablyfrom 0.1/1 to 10/1 of “carboxamide compound”/“QoI compound(s)”

Although the “composition” may be a mixture itself of a “carboxamidecompound” and “QoI compound(s)”, the “composition” is usually preparedby mixing a “carboxamide compound”, “QoI compound(s)” and an inertcarrier, and if necessary, by adding a surfactant and/or anotherauxiliary for formulation and by formulating the mixture into oilformulation, emulsifiable concentrate, flowable formulation, wettablepowder, water dispersible granules, powder, granules, or the like. Theformulation, which is used alone or by adding another inert component,can be used as a plant disease control agent.

The total content of a “carboxamide compound” and “QoI compound(s)” in a“composition” is usually from 0.1% to 99% by weight, preferably from0.2% to 90% by weight, and more preferably from 1% to 80% by weight.

Examples of the solid carriers used for the formulation include finepowder or granules of, for example, mineral materials such as kaolinclay, attapulgite, bentonite, montmorillonite, acid clay, pyrophillite,talc, diatomaceous earth and calcite; natural organic materials such ascorncob powder and walnut powder; synthesized organic materials such asurea; salts such as potassium carbonate and ammonium sulfate; syntheticinorganic materials such as synthesized hydrous silicon oxide.

Examples of the liquid carriers include aromatic hydrocarbons such asxylene, alkylbenzene and methylnaphthalene; alcohols such as 2-propanol,ethylene glycol, propylene glycol and ethylene glycol mono-ethyl ether;ketones such as acetone, cyclohexanone and isophorone; vegetable oilssuch as soybean oil and cotton seed oil; petrolic aliphatichydrocarbons; esters; dimethylsulfoxide; acetonitrile; and water

Examples of the surfactants include anionic surfactants such as alkylsulfate ester salts, alkylarylsulfonate salts, dialkylsulfosuccinatesalts, polyoxyethylene alkylaryl ether phosphoric acid ester salts,lignin sulfonate and naphthalene sulfonate formaldehyde polycondensedproducts; non-ionic surfactants such as polyoxyethylene alkyl arylethers, polyoxyethylene alkyl polyoxypropylene block copolymers andsorbitan fatty acid esters; and cationic surfactants such as alkyltrimethyl ammonium salts.

Examples of the other auxiliaries for formulation include water-solublepolymers such as polyvinyl alcohol and polyvinylpyrrolidone;polysaccharides such as gum arabic, alginic acid and its salt, CMC(carboxymethylcellulose) and xanthan gum; inorganic materials such asaluminum magnesium silicate and alumina sol; preservatives; coloringagents; and stabilizers such as PAP (acidic isopropyl phosphate) andBHT.

The “composition” can be also prepared by formulating a “carboxamidecompound” and “QoI compound(s)” according to the method as described inthe above, and then making the formulations or their diluents.

The “composition” can be used for protecting a plant from a plantdisease.

Example of plant diseases which can be controlled by the “composition”include the followings.

Rice diseases: Magnaporthe grisea, Cochliobolus miyabeanus, Rhizoctoniasolani, Gibberella fujikuroi;

Wheat diseases: Erysiphe graminis, Fusarium graminearum, F. avenaceum,F. culmorum, Microdochium nivale, Puccinia striiformis, P. graminis, P.recondita, Micronectriella nivale, Typhula sp., Ustilago tritici,Tilletia caries, Pseudocercosporella herpotrichoides, Mycosphaerellagraminicola, Stagonospora nodorum, Pyrenophora tritici-repentis;

Barley diseases: Erysiphe graminis, Fusarium graminearum, F. avenacerm,F. culmorum, Microdochium nivale, Puccinia striiformis, P. graminis, P.hordei, Ustilago nuda, Rhynchosporium secalis, Pyrenophora teres,Cochliobolus sativus, Pyrenophora graminea, Rhizoctonia solani;

Maize diseases: Ustilago maydis, Cochliobolus heterostrophus,Gloeocercospora sorghi, Puccinia polysora, Cercospora zeae-maydis,Rhizoctonia solani;

Citrus diseases: Diaporthe citri, Elsinoe fawcetti, Penicilliumdigitatum, P. italicum, Phytophthora parasitica, Phytophthoracitrophthora;

Apple diseases: Monilinia mali, Valsa ceratosperma, Podosphaeraleucotricha, Alternaria alternata apple pathotype, Venturia inaequalis,Colletotrichum acutatum, Phytophtora cactorum;

Pear diseases: Venturia nashicola, V. pirina, Alternaria alternataJapanese pear pathotype, Gymnosporangium haraeanum, Phytophtoracactorum;

Peach diseases: Monilinia fructicola, Cladosporium carpophilum,Phomopsis sp.;

Grape diseases: Elsinoe ampelina, Glomerella cingulata, Uninula necator,Phakopsora ampelopsidis, Guignardia bidwellii, Plasmopara viticola;

Persimmon diseases: Gloesporium kaki, Cercospora kaki, Mycosphaerelanawae;

Gourd diseases: Colletotrichum lagenarium, Sphaerotheca fuliginea,Mycosphaerella melonis, Fusarium oxysporum, Pseudoperonospora cubensis,Phytophthora sp., Pythium sp.;

Tomato diseases: Alternaria solani, Cladosporium fulvum, Phytophthorainfestans;

Eggplant diseases: Phomopsis vexans, Erysiphe cichoracearum;

Brassicaceous vegetable diseases: Alternaria japonica, Cercosporellabrassicae, Plasmodiophora brassicae, Peronospora parasitica;

Welsh onion diseases: Puccinia allii, Peronospora destructor;

Soybean diseases: Cercospora kikuchii, Elsinoe glycines, Diaporthephaseolorum var. sojae, Septoria glycines, Cercospora sojina, Phakopsorapachyrhizi, Phytophthora sojae, Rhizoctonia solani, Corynesporacasiicola, Sclerotinia sclerotiorum;

Kidney bean diseases: Colletrichum lindemthianum;

Peanut diseases: Cercospora personata, Cercospora arachidicola,Sclerotium rolfsii;

Pea diseases: Erysiphe pisi;

Potato diseases: Alternaria solani, Phytophthora infestans, Phytophthoraerythroseptica, Spongospora subterranean, f. sp. Subterranean;

Strawberry diseases: Sphaerotheca humuli, Glomerella cingulata;

Tea diseases: Exobasidium reticulatum, Elsinoe leucospila,Pestalotiopsis sp., Colletotrichum theae-sinensis;

Tobacco diseases: Alternaria longipes, Erysiphe cichoracearum,Colletotrichum tabacum, Peronospora tabacina, Phytophthora nicotianae;

Rapeseed diseases: Sclerotinia sclerotiorum, Rhizoctonia solani;

Cotton diseases: Rhizoctonia solani;

Beet diseases: Cercospora beticola, Thanatephorus cucumeris,Thanatephorus cucumeris, Aphanomyces cochlioides;

Rose diseases: Diplocarpon rosae, Sphaerotheca pannosa, Peronosporasparsa;

Diseases of chrysanthemum andasteraceae: Bremia lactuca, Septoriachrysanthemiindici, Puccinia horiana;

Diseases of various plants: Pythium aphanidermatum, Pythium debarianum,Pythium graminicola, Pythium irregulare, Pythium ultimum, Botrytiscinerea, Sclerotinia sclerotiorum;

Radish diseases: Alternaria brassicicola;

Zoysia diseases: Sclerotinia homeocarpa, Rhizoctonia solani;

Banana diseases: Mycosphaerella fijiensis, Mycosphaerella musicola;

Sunflower diseases: Plasmopara halstedii;

Seed diseases or diseases in the initial stage of growth of variousplants caused by Aspergillus spp., Penicillium spp., Fusarium spp.,Gibberella spp., Tricoderma spp., Thielaviopsis spp., Rhizopus spp.,Mucor spp., Corticium spp., Rhoma spp., Rhizoctonia spp., Diplodia spp.,or the like;

Virus diseases of various plants mediated by Polymixa spp., Olpidiumspp. or the like.

Examples of the plants for which the “composition” can be used are asfollows:

Agricultural crops: maize, rice, wheat, barley, rye, oat, sorghum,cotton, soybean, peanut, backwheat, sugar beet, rapeseed, sunflower,sugar cane, tobacco, and the like;

Vegetables: Solanaceous vegetables (eggplant, tomato, green pepper, hotpepper, potato, etc.), Cucurbitaceous vegetables (cucumber, pumpkin,zucchini, watermelon, melon, squash, etc.); Cruciferous vegetables(radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, brownmustard, broccoli, cauliflower, etc.), Asteraceous vegetables (burdock,garland chrysanthemum, artichoke, lettuce, etc.), Liliaceous vegetables(Welsh onion, onion, garlic, asparagus, etc.), Umbelliferous vegetables(carrot, parsley, celery, parsnip, etc.), Chenopodiaceous vegetables(spinach, chard, etc.), Lamiaceous vegetables (Japanese basil, mint,basil, etc.), strawberry, sweet potato, yam, aroid, and the like;

Flowering plants;

Ornamental foliage plants;

Turf;

Fruit trees: pome fruits (apple, common pear, Japanese pear, Chinesequince, quince, etc.), stone fruits (peach, plum, nectarine, Japaneseplum, cherry, apricot, prune, etc.), citrus (mandarin, orange, lemon,lime, grapefruit, etc.), nuts (chestnut, walnut, hazel nut, almond,pistachio, cashew nut, macadamia nut, etc.), berry fruits (blueberry,cranberry, blackberry, raspberry, etc.), grape, persimmon, olive,loquat, banana, coffee, date, coconut palm, and the like;

Trees other than fruit trees: tea, mulberry, flowering trees, streettrees (ash tree, birch, dogwood, eucalyptus, ginkgo, lilac, maple tree,oak, poplar, cercis, Chinese sweet gum, plane tree, zelkova, Japanesearborvitae, fir tree, Japanese hemlock, needle juniper, pine, spruce,yew), and the like.

The above-described plants may be those having resistance imparted bygenetic engineering technique.

Among the above plants, the “composition” is expected to have excellentcontrolling effect particularly to plant diseases caused in soybean.

Among the above plant diseases, soybean diseases to which especiallyexcellent effect of the “composition” can be expected are Rhizoctoniasolani, Cercospora kikuchii, Septoria glycines, Corynespora casiicola,Phakopsora pachyrizi, Sclerotinia sclerotiorum, Cercospora sojina, andthe like.

Following compositions exemplify an embodiment of the “composition”:

a composition comprising “carboxamide compound (1)” and dimoxystrobin;

a composition comprising “carboxamide compound (1)” and azoxystrobin;

a composition comprising “carboxamide compound (1)” and fluoxastrobin;

a composition comprising “carboxamide compound (1)” and pyraclostrobin;

a composition comprising “carboxamide compound (1)” and kresoxim-methyl;

a composition comprising “carboxamide compound (1)” and picoxystrobin;

a composition comprising “carboxamide compound (1)” and trifloxystrobin;

a composition comprising “carboxamide compound (1)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide;

a composition comprising “carboxamide compound (2)” and dimoxystrobin;

a composition comprising “carboxamide compound (2)” and azoxystrobin;

a composition comprising “carboxamide compound (2)” and fluoxastrobin;

a composition comprising “carboxamide compound (2)” and pyraclostrobin;

a composition comprising “carboxamide compound (2)” and kresoxim-methyl;

a composition comprising “carboxamide compound (2)” and picoxystrobin;

a composition comprising “carboxamide compound (2)” and trifloxystrobin;

a composition comprising “carboxamide compound (2)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide;

a composition comprising “carboxamide compound (3)” and dimoxystrobin;

a composition comprising “carboxamide compound (3)” and azoxystrobin;

a composition comprising “carboxamide compound (3)” and fluoxastrobin;

a composition comprising “carboxamide compound (3)” and pyraclostrobin;

a composition comprising “carboxamide compound (3)” and kresoxim-methyl;

a composition comprising “carboxamide compound (3)” and picoxystrobin;

a composition comprising “carboxamide compound (3)” and trifloxystrobin;

a composition comprising “carboxamide compound (3)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide;

a composition comprising “carboxamide compound (4)” and dimoxystrobin;

a composition comprising “carboxamide compound (4)” and azoxystrobin;

a composition comprising “carboxamide compound (4)” and fluoxastrobin;

a composition comprising “carboxamide compound (4)” and pyraclostrobin;

a composition comprising “carboxamide compound (4)” and kresoxim-methyl;

a composition comprising “carboxamide compound (4)” and picoxystrobin;

a composition comprising “carboxamide compound (4)” and trifloxystrobin;

a composition comprising “carboxamide compound (4)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide;

a composition comprising “carboxamide compound (5)” and dimoxystrobin;

a composition comprising “carboxamide compound (5)” and azoxystrobin;

a composition comprising “carboxamide compound (5)” and fluoxastrobin;

a composition comprising “carboxamide compound (5)” and pyraclostrobin;

a composition comprising “carboxamide compound (5)” and kresoxim-methyl;

a composition comprising “carboxamide compound (5)” and picoxystrobin;

a composition comprising “carboxamide compound (5)” and trifloxystrobin;

a composition comprising “carboxamide compound (5)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide.

a composition comprising “carboxamide compound (1)” and dimoxystrobin inwhich the weight ratio of “carboxamide compound (1)” to dimoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and azoxystrobin inwhich the weight ratio of “carboxamide compound (1)” to azoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and fluoxastrobin inwhich the weight ratio of “carboxamide compound (1)” to fluoxastrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and pyraclostrobinin which the weight ratio of “carboxamide compound (1)” topyraclostrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and kresoxim-methylin which the weight ratio of “carboxamide compound (1)” tokresoxim-methyl is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and picoxystrobin inwhich the weight ratio of “carboxamide compound (1)” to picoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” and trifloxystrobinin which the weight ratio of “carboxamide compound (1)” totrifloxystrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (1)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamidein which the weight ratio of “carboxamide compound (1)” toN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamideis 0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and dimoxystrobin inwhich the weight ratio of “carboxamide compound (2)” to dimoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and azoxystrobin inwhich the weight ratio of “carboxamide compound (2)” to azoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and fluoxastrobin inwhich the weight ratio of “carboxamide compound (2)” to fluoxastrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and pyraclostrobinin which the weight ratio of “carboxamide compound (2)” topyraclostrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and kresoxim-methylin which the weight ratio of “carboxamide compound (2)” tokresoxim-methyl is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and picoxystrobin inwhich the weight ratio of “carboxamide compound (2)” to picoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” and trifloxystrobinin which the weight ratio of “carboxamide compound (2)” totrifloxystrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (2)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyllphenylacetamidein which the weight ratio of “carboxamide compound (2)” toN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyllphenylacetamideis 0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and dimoxystrobin inwhich the weight ratio of “carboxamide compound (3)” to dimoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and azoxystrobin inweight ratio of “carboxamide compound (3)” to azoxystrobin is 0.1/1 to10/1;

a composition comprising “carboxamide compound (3)” and fluoxastrobin inwhich the weight ratio of “carboxamide compound (3)” to fluoxastrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and pyraclostrobinin which the weight ratio of “carboxamide compound (3)” topyraclostrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and kresoxim-methylin which the weight ratio of “carboxamide compound (3)” tokresoxim-methyl is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and picoxystrobin inwhich the weight ratio of “carboxamide compound (3)” to picoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” and trifloxystrobinin which the weight ratio of “carboxamide compound (3)” totrifloxystrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (3)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamidein which the weight ratio of “carboxamide compound (3)” toN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamideis 0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and dimoxystrobin inwhich the weight ratio of “carboxamide compound (4)” to dimoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and azoxystrobin inwhich the weight ratio of “carboxamide compound (4)” to azoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and fluoxastrobin inwhich the weight ratio of “carboxamide compound (4)” to fluoxastrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and pyraclostrobinin which the weight ratio of “carboxamide compound (4)” topyraclostrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and kresoxim-methylin which the weight ratio of “carboxamide compound (4)” tokresoxim-methyl is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and picoxystrobin inwhich the weight ratio of “carboxamide compound (4)” to picoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” and trifloxystrobinin which the weight ratio of “carboxamide compound (4)” totrifloxystrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (4)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyllphenylacetamidein which the weight ratio of “carboxamide compound (4)” toN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyllphenylacetamideis 0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and dimoxystrobin inwhich the weight ratio of “carboxamide compound (5)” to dimoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and azoxystrobin inwhich the weight ratio of “carboxamide compound (5)” to azoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and fluoxastrobin inwhich the weight ratio of “carboxamide compound (5)” to fluoxastrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and pyraclostrobinin which the weight ratio of “carboxamide compound (5)” topyraclostrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and kresoxim-methylin which the weight ratio of “carboxamide compound (5)” tokresoxim-methyl is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and picoxystrobin inwhich the weight ratio of “carboxamide compound (5)” to picoxystrobin is0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” and trifloxystrobinin which the weight ratio of “carboxamide compound (5)” totrifloxystrobin is 0.1/1 to 10/1;

a composition comprising “carboxamide compound (5)” andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamidein which the weight ratio of “carboxamide compound (5)” toN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamideis 0.1/1 to 10/1;

The method of controlling plant disease (hereinafter referred to as“controlling method”) can be carried out by treating a plant or the soilwhere a plant grows with an effective amount of a “carboxamide compound”and “QoI compound (s)”.

The part of plant to be treated is stem and leaf of a plant, seed orbulb of a plant, and the bulb means bulb, corm, rootstock, tuber,tuberous root and rhizophore.

In the “controlling method”, the treatment of a plant or the soil wherea plant grows with a “carboxamide compound” and “QoI compound(s)” can becarried out separately at the same timing, but the treatment is usuallycarried out by using a “composition” in light of convenience.

In the “controlling method”, the treatment with a carboxamide compound”and “QoI compound(s)” is, for example, stems and leaves application,soil application, roots application or seeds application.

Examples of the stems and leaves application include a treatment forsurface of cultivated plant by a stem and leaves spray or a stem andtree spray.

Examples of the root application include a method of dipping a wholeplant or root of a plant into a liquid containing a “carboxamidecompound” and “QoI compound (s)” and a method of sticking a solidpreparation comprising a “carboxamide compound”, “QoI compound(s)” and asolid carrier onto root of a plant.

Examples of the soil application include a method of spraying a“composition” onto a soil, a method of mixing a “composition” with asoil and a method of irrigating a “composition” into the soil.

Examples of the seed application include a method of treating seeds orbulbs of a plant to be protected from a plant disease with a“composition”. Particularly, the application can be carried out byspraying a suspension of a “composition” to the surface of seeds or thebulbs, or by spreading wettable powder, emulsifiable concentrate orflowable formulation itself or a mixture thereof with a small amount ofwater on the seeds or the bulbs, or by dipping the seeds into a solutionof a “composition” for a prescribed time, by film coating application orpellet coating application.

The amount of a “carboxamide compound” and “QoI compound(s)” used in the“controlling method” is different depending on the kind of a plant to betreated, the kind of a plant disease to be controlled and its frequency,the kind of a formulation, timing of treatment, method of treatment,place of treatment, weather condition, and the like.

When a “composition” is applied to stems and/or leaves of a plant or tothe soil where a plant grows, the total amount of a “carboxamidecompound” and “QoI compound(s)” is usually from 1 g to 500 g/1000 m²,preferably from 2 g to 200 g/1000 m², and more preferably from 10 g to100 g/1000 m².

When a “composition” is applied to seeds of a plant, the total amount ofa “carboxamide compound” and “QoI compound(s)” is usually from 0.001 gto 10 g/1 kg of the seeds, and preferably from 0.01 g to 1 g/1 kg of theseeds.

An emulsifiable concentrate, wettable powder or flowable formulation isused usually by diluting the formulation with water and spraying thediluted formulation. In this case, the concentration of a “carboxamidecompound” and “QoI compound(s)” in total of the diluted formulation isusually from 0.0005% to 2% by weight, and preferably from 0.005% to 1%by weight.

A powder formulation, granule formulation, and the like is usually usedwithout dilution.

EXAMPLE

The present invention is further explained in detail with FormulationExamples and Test Examples. However, the present invention is notlimited by the following Examples.

In the following Examples, “part” means “part by weight” unlessotherwise provided.

Formulation Example 1

One of “carboxamide compounds” (1) to (5) (2.5 parts), dimoxystrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 2

One of “carboxamide compounds” (1) to (5) (2.5 parts), azoxystrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 3

One of “carboxamide compounds” (1) to (5) (2.5 parts), fluoxastrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 4

One of “carboxamide compounds” (1) to (5) (2.5 parts), pyraclostrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 5

One of “carboxamide compounds” (1) to (5) (2.5 parts), kresoxim-methyl(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 6

One of “carboxamide compounds” (1) to (5) (2.5 parts), picoxystrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 7

One of “carboxamide compounds” (1) to (5) (2.5 parts), trifloxystrobin(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 8

One of “carboxamide compounds” (1) to (5) (2.5 parts),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(1.25 parts), polyoxyethylene styryl phenyl ether (14 parts), calciumdodecylbenzene sulfonate (6 parts) and xylene (76.25 parts) arethoroughly mixed to give each of formulations, respectively.

Formulation Example 9

One of “carboxamide compounds” (1) to (5) (2 parts), dimoxystrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and milled by wet-milling method to give each offormulations, respectively.

Formulation Example 10

One of “carboxamide compounds” (1) to (5) (2 parts), azoxystrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 11

One of “carboxamide compounds” (1) to (5) (2 parts), fluoxastrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 12

One of “carboxamide compounds” (1) to (5) (2 parts), pyraclostrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 13

One of “carboxamide compounds” (1) to (5) (2 parts), kresoxim-methyl (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 14

One of “carboxamide compounds” (1) to (5) (2 parts), picoxystrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 15

One of “carboxamide compounds” (1) to (5) (2 parts), trifloxystrobin (8parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 16

One of “carboxamide compounds” (1) to (5) (2 parts),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(8 parts), a mixture of white carbon and polyoxyethylene alkyl ethersulfate ammonium salt (ratio by weight 1:1) (35 parts) and water (55parts) are mixed and the mixture is milled by wet-milling method to giveeach of formulations, respectively.

Formulation Example 17

One of “carboxamide compounds” (1) to (5) (5 parts), dimoxystrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 18

One of “carboxamide compounds” (1) to (5) (5 parts), azoxystrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 19

One of “carboxamide compounds” (1) to (5) (5 parts), fluoxastrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 20

One of “carboxamide compounds” (1) to (5) (5 parts), pyraclostrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 21

One of “carboxamide compounds” (1) to (5) (5 parts), kresoxim-methyl (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 22

One of “carboxamide compounds” (1) to (5) (5 parts), picoxystrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 23

One of “carboxamide compounds” (1) to (5) (5 parts), trifloxystrobin (10parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution (28.5parts) containing polyvinyl alcohol (2 parts) are mixed and the mixtureis milled by wet-milling method. To the milled mixture is added anaqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 24

One of “carboxamide compounds” (1) to (5) (5 parts),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(10 parts), sorbitan tri-oleate (1.5 parts) and an aqueous solution(28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and themixture is milled by wet-milling method. To the milled mixture is addedan aqueous solution (45 parts) containing xanthan gum (0.05 parts) andaluminum magnesium silicate (0.1 part), and further propylene glycol (10parts) is added to the mixture. The resultant mixture is mixed bystirring to give each of formulations, respectively.

Formulation Example 25

One of “carboxamide compounds” (1) to (5) (1 part), dimoxystrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are thoroughly mixed and milled. Water is added to the mixtureand the mixture is sufficiently kneaded, granulated and then dried togive each of formulations, respectively.

Formulation Example 26

One of “carboxamide compounds” (1) to (5) (1 part), azoxystrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are thoroughly mixed and milled. Water is added to the mixtureand the mixture is sufficiently kneaded, granulated and then dried togive each of formulations, respectively.

Formulation Example 27

One of “carboxamide compounds” (1) to (5) (1 part), fluoxastrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are thoroughly mixed and milled. Water is added to the mixtureand the mixture is sufficiently kneaded, granulated and then dried togive each of formulations, respectively.

Formulation Example 28

One of “carboxamide compounds” (1) to (5) (1 part), pyraclostrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are thoroughly mixed and milled. Water is added to the mixtureand the mixture is sufficiently kneaded, granulated and then dried togive each of formulations, respectively.

Formulation Example 29

One of “carboxamide compounds” (1) to (5) (1 part), kresoxim-methyl (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are thoroughly mixed and milled. Water is added to the mixtureand the mixture is sufficiently kneaded, granulated and then dried togive each of formulations, respectively.

Formulation Example 30

One of “carboxamide compounds” (1) to (5) (1 part), picoxystrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are mixed well and milled. Water is added to the mixture and themixture is sufficiently kneaded, granulated and then dried to give eachof formulations, respectively.

Formulation Example 31

One of “carboxamide compounds” (1) to (5) (1 part), trifloxystrobin (4parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are mixed well and milled. Water is added to the mixture and themixture is sufficiently kneaded, granulated and then dried to give eachof formulations, respectively.

Formulation Example 32

One of “carboxamide compounds” (1) to (5) (1 part),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(4 parts), synthesized hydrous silicon oxide (1 part), calciumligninsulfonate (2 parts), bentonite (30 parts) and kaolin clay (62parts) are mixed well and milled. Water is added to the mixture and themixture is sufficiently kneaded, granulated and then dried to give eachof formulations, respectively.

Formulation Example 33

One of “carboxamide compounds” (1) to (5) (12.5 parts),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(37.5 parts), calcium ligninsulfonate (3 parts), sodium laurylsulfate (2parts) and synthesized hydrous silicon oxide (45 parts) are thoroughlymixed and milled to give each of formulations, respectively.

Formulation Example 34

One of “carboxamide compounds” (1) to (5) (3 parts),N-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide(2 parts), kaolin clay (85 parts) and talc (10 parts) are thoroughlymixed and milled to give each of formulations, respectively.

Test Examples using each of the “compositions” are shown in thefollowing.

Test Example 1

A cyclohexanone solution (100 microL) containing prescribed amount(weight) of test compounds was applied on seeds of soybean(variety:Natto Shoryu) (10 g) by using a rotary apparatus for seedtreatment (Seed dresser, manufactured by Hans-Ulrich Hege GmbH).

One day after the application, plastic pot was filled with soilcontaminated by Rhizoctonia solani, and the seeds treated with the testcompounds were seeded in the soil and cultivated in a glass-greenhousefor 20 days (hereinafter referred to as “treated plot”).

Thereafter, the presence of disease caused by Rhizoctonia solani in theyoung plants which germinated from each seed was observed and diseaseseverity was calculated by the following calculation formula (1).

On the other hand, seeds of soybean which were not treated as above werecultivated in the same way as above (hereinafter referred to as“non-treated plot”) and the disease severity in “non-treated plot” wascalculated in the same way as above “treated plot”.

On the basis of the above disease severity in “treated plot” and“non-treated plot”, efficacy in “treated plot” was evaluated by thefollowing calculation formula (2).

The results are shown in Table 1 to Table 6.

Disease degree (%)=(number of infected young plants/total number ofyoung plants)×100   Calculation formula (1):

Efficacy (%)=[1−(disease severity in “treated plot”/disease severity in“non-treated plot”)]×100   Calculation formula (2):

TABLE 1 “carboxamide compound (1)” azoxystrobin efficacy [g/100 kg ofseeds] [g/100 kg of seeds] (%) 2 2 100

TABLE 2 “carboxamide compound (5)” azoxystrobin efficacy [g/100 kg ofseeds] [g/100 kg of seeds] (%) 2 2 100

TABLE 3 “carboxamide compound (1)” pyraclostrobin efficacy [g/100 kg ofseeds] [g/100 kg of seeds] (%) 2 2 100

TABLE 4 “carboxamide compound (5)” pyraclostrobin [g/100 kg of seeds][g/100 kg of seeds] efficacy (%) 2 2 100

TABLE 5 “carboxamide N-methyl-α- compound (1)” methoxyimino-2-[(2,5-[g/100 kg of dimethylphenoxy)methyl]phenylacetamide seeds] [g/100 kg ofseeds] efficacy (%) 2 2 100

TABLE 6 “carboxamide N-methyl-α- compound (5)” methoxyimino-2-[(2,5-[g/100 kg of dimethylphenoxy)methyl]phenylacetamide seeds] [g/100 kg ofseeds] efficacy (%) 2 2 100

Test Example 2

A plastic pot was filled a soil, and soybean seeds (variety: NattoShoryu) were seeded in the soil and grown in a greenhouse for 14 days.Test compounds were dissolved in CEC cocktail (cyclohexanone: Solpol™2680X (manufactured by Toho Kagaku Kogyo)=5:1 (by volume)) to give anemulsifiable concentrate containing total amount 5% (w/v) of the testcompounds. The emulsifiable concentrate was mixed with water to give aprescribed concentration. The mixture was sprayed on leaves of thesoybean so as to stick sufficiently thereto. After the spraying, theplant was air-dried, and one day after, the plant was inoculated with anaqueous suspension containing urediniospore of Phakopsora pachyrhizi(about 10,000/ml) by spraying the suspension. After the inoculation, theplant was left in humid circumstance at 20-23° C. for one day and thencultivated in a greenhouse for 10 days (hereinafter referred to as“treated plot”). Thereafter, lesion area of Phakopsora pachyrhizi wasinvestigated.

On the other hand, soybean was cultivated in the same way as above“treated plot” except for that the plant was not treated with themixture containing the test compounds (hereinafter referred to as“non-treated plot”), and the lesion area of Phakopsora pachyrhizi wereinvestigated in the same way as above.

On the basis of the above stigmata area in the “treated plot” and“non-treated plot”, efficacy in “treated plot” was evaluated accordingto the following calculation formula (3).

Efficacy (%)=[1−(lesion area in “treated plot”/lesion area in“non-treated plot”)]×100   Calculation formula (3):

The results are shown in the following Table 7 to Table 18.

TABLE 7 “carboxamide compound (1)” trifloxystrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 8 “carboxamide compound (5)” trifloxystrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 9 “carboxamide compound (1)” azoxystrobin [ppm] [ppm] efficacy (%)2 2 100

TABLE 10 “carboxamide compound (5)” azoxystrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 11 N-methyl-α- “carboxamide methoxyimino-2-[(2,5- compound (1)”dimethylphenoxy)methyl]phenylacetamide [ppm] [ppm] efficacy (%) 2 10 100

TABLE 12 N-methyl-α- “carboxamide methoxyimino-2-[(2,5- compound (5)”dimethylphenoxy)methyl]phenylacetamide [ppm] [ppm] efficacy (%) 2 10 100

TABLE 13 “carboxamide compound (1)” pyraclostrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 14 “carboxamide compound (5)” pyraclostrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 15 “carboxamide compound (1)” picoxystrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 16 “carboxamide compound (5)” picoxystrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 17 “carboxamide compound (1)” fluoxastrobin [ppm] [ppm] efficacy(%) 2 2 100

TABLE 18 “carboxamide compound (5)” fluoxastrobin [ppm] [ppm] efficacy(%) 2 2 100

INDUSTRIAL APPLICABILITY

A plant disease control composition comprising a “carboxamide compound”represented by formula (I) and one or more azole compounds selected fromgroup (A) is useful for controlling plant disease.

1. A plant disease control composition comprising a carboxamide compoundrepresented by formula (I):

wherein R¹ represents a hydrogen atom or a methyl group, and R²represents a methyl group, a difluoromethyl group or a trifluoromethylgroup, and one or more QoI compounds selected from group (A) consistingof dimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin,kresoxim-methyl, picoxystrobin, trifloxystrobin andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide.2. The plant disease control composition according to claim 1, whereinthe weight ratio of the carboxamide compound to the QoI compound(s) isfrom 0.1/1 to 10/1 of the carboxamide compound/the QoI compound(s).
 3. Amethod of controlling plant disease which comprises a step of treating aplant or the soil where a plant grows with an effective amount of acarboxamide compound represented by formula (I):

wherein R¹ represents a hydrogen atom or a methyl group, and R²represents a methyl group, a difluoromethyl group or a trifluoromethylgroup, and one or more QoI compounds selected from group (A) consistingof dimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin,kresoximmethyl, picoxystrobin, trifloxystrobin andN-methyl-alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide.4. The method of controlling plant disease according to claim 3, whereinthe weight ratio of the carboxamide compound to the QoI compound(s) isfrom 0.1/1 to 10/1 of the carboxamide compound/the QoI compound(s). 5.The method of controlling plant disease according to claim 3 or claim 4,wherein the plant or the soil where a plant grows is soybean or the soilwhere soybean grows, respectively.